CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,072,536 | +20.5% | 71,934 | -11.5% | 0.00% | +50.0% |
Q2 2023 | $890,399 | +30.7% | 81,315 | +4.1% | 0.00% | 0.0% |
Q1 2023 | $681,241 | +1161.6% | 78,124 | +427.9% | 0.00% | – |
Q3 2021 | $54,000 | -76.8% | 14,800 | -72.3% | 0.00% | – |
Q2 2021 | $233,000 | -69.6% | 53,400 | -68.4% | 0.00% | -100.0% |
Q1 2021 | $766,000 | -7.7% | 168,800 | +16.7% | 0.00% | 0.0% |
Q4 2020 | $830,000 | +131.2% | 144,600 | +191.5% | 0.00% | +100.0% |
Q3 2020 | $359,000 | +303.4% | 49,600 | +95.3% | 0.00% | – |
Q2 2020 | $89,000 | -56.2% | 25,400 | -75.4% | 0.00% | -100.0% |
Q4 2019 | $203,000 | -61.6% | 103,400 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $529,000 | -75.4% | 103,400 | -65.6% | 0.00% | -83.3% |
Q2 2019 | $2,152,000 | -44.7% | 300,521 | +2.6% | 0.01% | -45.5% |
Q1 2019 | $3,891,000 | +59.7% | 293,021 | -5.4% | 0.01% | +37.5% |
Q4 2018 | $2,437,000 | -14.8% | 309,603 | +20.0% | 0.01% | 0.0% |
Q3 2018 | $2,859,000 | +45.5% | 258,003 | +76.2% | 0.01% | +33.3% |
Q2 2018 | $1,965,000 | +16.5% | 146,403 | +12.8% | 0.01% | +20.0% |
Q1 2018 | $1,686,000 | – | 129,803 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |